KDP vs RXRX · P/E 23, rev $11.29B vs rev $14.1M
Keurig Dr Pepper Inc (KDP) versus Recursion Pharmaceuticals Inc (RXRX) — a side-by-side from cached financials, not a winner call.
Keurig Dr Pepper Inc (KDP) is a beverages - non-alcoholic company listed on NASDAQ.
Recursion Pharmaceuticals Inc (RXRX) is a biotechnology company listed on NASDAQ.
Latest reported KDP revenue for 2026-06-30 was $11.29B. Net income was $412.0M. KDP currently screens at market cap $42.03B and trailing P/E 22.9.
Latest reported RXRX revenue for 2026-06-30 was $14.1M. Net income was -$248.5M. RXRX currently screens at market cap $1.75B.
KDP currently screens at market cap $42.03B and trailing P/E 22.9. RXRX currently screens at market cap $1.75B.
Not investment advice. Open the KDP and RXRX stock pages for the full models.
Not investment advice.